Truth Pharm Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2016 | 37,281 | 32,425 | 4,856 | 1.8 | — |
| 2017 | 135,762 | 53,736 | 82,026 | 19.4 | — |
| 2018 | 136,729 | 85,774 | 50,955 | 19.3 | — |
| 2019 | 278,288 | 165,376 | 112,912 | 18.2 | 52% |
| 2020 | 443,711 | 417,806 | 25,905 | 7.9 | 32% |
| 2021 | 400,707 | 264,668 | 136,039 | 18.7 | 46% |
| 2022 | 231,660 | 396,241 | −164,581 | 7.5 | 48% |
| 2023 | 399,380 | 449,463 | −50,083 | 5.3 | 43% |
In its most recent public year (2023), this organization spent $50,083 more than it brought in. Its reserves stood at about 5.3 months of spending, up from 1.8 in 2016. Staff pay was 43% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Truth Pharm Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works